loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Clopidogrel Bisulphate.

Menu
$ API Ref.Price (USD/KG) : 154Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Sanofi-Aventis Canada Inc.

02 1Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2019-06-10

Date Granted : 2005-03-15

Clopidogrel

Brand Name : PLAVIX

Patent Number : 2334870

Filing Date : 1999-06-10

Strength per Unit : 75 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-10

Date Granted : 2005-03-15

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2012-08-22

Date Granted : 1995-08-22

Clopidogrel

Brand Name : PLAVIX

Patent Number : 1336777

Filing Date : 1988-02-08

Strength per Unit : 75 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-08-22

Date Granted : 1995-08-22

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2012-08-22

Date Granted : 1995-08-22

Clopidogrel

Brand Name : PLAVIX

Patent Number : 1336777

Filing Date : 1988-02-08

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-08-22

Date Granted : 1995-08-22

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2019-06-10

Date Granted : 2005-03-15

Clopidogrel

Brand Name : PLAVIX

Patent Number : 2334870

Filing Date : 1999-06-10

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-10

Date Granted : 2005-03-15

Sanofi Company Banner

05

arrow
Formnext Forum
Not Confirmed

Country
arrow
Formnext Forum
Not Confirmed

Clopidogrel

Brand Name :

Patent Number : 1194875

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-07-08

Date Granted :

blank